Calpain mediates calcium-induced activation of the Erk 1,2 MARK pathway and cytoskeletal phosphorylation in neurons: Relevance to alzheimer's disease

American Journal of Pathology

Volumn 165, Issue 3, 2004, Pages 795-805

  Veeranna, ^a,b   Kaji, Takahide ^c   Boland, Barry ^a,b   Odrljin, Tatjana ^a   Mohan, Panaiyur ^a,b   Basavarajappa, Balapal S ^a   Peterhoff, Corrinne ^a   Cataldo, Anne ^a,d   Rudnicki, Anna ^d   Amin, Niranjana ^e   Li, Bing Sheng ^e   Pant, Harish C ^e   Hungund, Basalingappa L ^a   Arancio, Ottavio ^a,b   Nixon, Ralph A ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Mitsubishi Tokyo Pharmaceuticals Inc   (Japan)

^d MCLEAN HOSPITAL   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANTISENSE OLIGONUCLEOTIDE; CALCIUM; CALPAIN; CALPASTATIN; CALPEPTIN; IONOMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEOCORTEX; NEUROFILAMENT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; RAT;

EID: 4344566337     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63342-1     Document Type: Article

References (74)

1. Sternberger NH, Sternberger LA, Ulrich J: Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci USA 1985, 82:4274-4276
2. Trojanowski JQ, Walkenstein N, Lee VM: Expression of neurofilament subunits in neurons of the central and peripheral nervous system: an immunohistochemical study with monoclonal antibodies. J Neurosci 1986, 6:650-660
3. Julien J: Neurofilament functions in health and disease. Curr Opin Neurobiol 1999, 9:554-560
4. Lavedan C, Buchholtz S, Nussbaum R, Albin R, Polymeropoulos M: A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci Lett 2002, 322:57-61
5. Al-Chalabi A, Miller C: Neurofilaments and neurological disease. Bioessays 2003, 25:346-355
6. Nixon RA, Sihag RK: Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci 1991, 14:501-506
7. Nixon RA: The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiology. Brain Pathol 1993, 3:29-38
8. Pant HC, Veeranna, Grant P: Regulation of axonal neurofilament phosphorylation. Curr Top Cell Regul 2000, 36:133-150
9. Lee V, Otvos Jr L, Carde M, Hollosi M, Dietzschold B, Lazzarini R: Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc Natl Acad Sci USA 1988, 85:1998-2002
10. Otvos LJ, Hollosi M, Perczel A, Dietzschold B, Fasman GD: Phosphorylation loops in synthetic peptides of the human neurofilament protein middle-sized subunit. J Protein Chem 1988, 7:365-376
11. Vechio J, Bruijn L, Xu Z, Brown RJ, Cleveland D: Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann Neural 1996, 40:603-610
12. Lacoste-Royal G, Mathieu M, Gauvreau D: Hincll RFLP in the human gene for the heavy neurofilament subunit (NF-H). Nucleic Acids Res 1989, 17:6434
13. Wang J, Tung YC, Wang Y, Li XT, Iqbal K, Grundke-Iqbal I: Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett 2001, 507:81-87
14. Dixon M, Bub D, Chertkow H, Arguin M: Object identification deficits in dementia of the Alzheimer type: combined effects of semantic and visual proximity. J Int Neuropsychol Soc 1999, 5:330-345
15. Campbell MJ, Morrison JH: Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J Comp Neural 1989, 282:191-205
16. Morrison JH, Lewis DA, Campbell MJ, Huntley GW, Benson DL, Bouras C: A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res 1987, 416:331-336
17. Brion J, Smith C, Couck A, Gallo J, Anderton B: Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem 1993, 61:2071-2080
18. Lovestone S, Reynolds C: The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997, 78:309-324
19. Lovestone S: Early diagnosis and the clinical genetics of Alzheimer's disease. J Neural Sci 1999, 246:69-72
20. Robinson MJ, Cobb MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997, 9:180-186
21. Saitoh T, Masliah E, Jin L, Cole G, Wieloch T, Shapiro I: Protein kinases and phosphorylation in neurologic disorders and cell death. Lab Invest 1991, 64:596-616
22. Rapoport M, Ferreira A: PD98059 prevents neunte degeneration induced by fibrillar β-amyloid in mature hippocampal neurons. J Neurochem 2000, 74:125-133
23. Veeranna, Amin ND, Ahn NG, Jaffe H, Winters CA, Grant P, Pant HC: Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 1998, 18:4008-4021
24. Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I: Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res Mol Brain Res 2002, 109:45-55
25. Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Vinals F, Ribalta T: Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy, and corticobasal degeneration. Brain Pathol 2001, 11:144-158
26. Mirra S, Heyman A, McKeel D, Sumi S, Grain B, Brownlee L, Vogel F, Hughes J, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 1991, 41:479-486
27. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259
28. Veeranna, Shetty KT, Link WT, Jaffe H, Wang J, Pant HC: Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J Neurochem 1995, 64:2681-2690
29. Dzandu J, Johnson J, Wise G: Sodium dodecyl sulfate-gel electrophoresis: staining of polypeptides using heavy metal salts. Anal Biochem 1988, 174:157-167
30. Arancio O, Lev-Ram V, Tsien R, Kandel E, Hawkins R: Nitric oxide acts as a retrograde messenger during long-term potentiation in cultured hippocampal neurons. J Physiol (Paris) 1996, 90:321-322
31. Oberto A, Marks N, Evans H, Guidotti A: Lead (Pb+2) promotes apoptosis in newborn rat cerebellar neurons: pathological implications. J Pharmacol Exp Ther 1996, 279:435-442
32. Cataldo AM, Thayer CY, Bird ED, Wheelock TR, Nixon RA: Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res 1990, 513:181-192
33. Veeranna, Shetty KT, Amin N, Grant P, Albers RW, Pant HC: Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18. Neurochem Res 1996, 21:629-636
34. Grynspan F, Griffin WR, Cataldo A, Katayama S, Nixon RA: Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res 1997, 763:145-158
35. Saito K, Elce JS, Hamos JE, Nixon RA: Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993, 90:2628-2632
36. Myers MW, Lazzarini RA, Lee VM, Schlaepfer WW, Nelson DL: The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J 1987, 6:1617-1626
37. Shetty KT, Link WT, Pant HC: cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc Natl Acad Sci USA 1993, 90:6844-6848
38. Morrison JH, Hof PR: Life and death of neurons in the aging brain. Science 1997, 278:412-419
39. Morrison JH, Hof PR: Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res 2002, 136:467-486
40. Collatz M, Rudel R, Brinkmeier H: Intracellular calcium chelator BAPTA protects cells against toxic calcium overload but also alters physiological calcium responses. Cell Calcium 1997:453-459
41. Johnson GV, Guttmann RP: Calpains: intact and active? Bioessays 1997, 19:1011-1018
42. Ekinci FJ, Shea TB: Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC. Brain Res 1999, 850:207-216
43. Yamakawa H, Banno Y, Nakashima S, Yoshimura S, Sawada M, Nishimura Y, Nozawa Y, Sakai N: Crucial role of calpain in hypoxic PC12 cell death: calpain, but not caspases, mediates degradation of cytoskeletal proteins and protein kinase C-α and δ. Neurol Res 2001, 23:522-530
44. Nixon RA, Saito KI, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea TB, Beermann M: Calcium-activated neutral proteinase calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 1994, 747:77-91
45. Verkhratsky A, Toescu EC: Calcium and neuronal ageing. Trends Neurosci 1998, 21:2-7
46. O'Neill C, Cowburn R, Bonkale W, Ohm T, Fastbom J, Carmody M, Kelliher M: Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease. Biochem Soc Symp 2001, 67:177-194
47. Mattson M, Chan S: Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 2003, 34:385-397
48. Adamec E, Murrell J, Takao M, Hobbs W, Nixon R, Ghetti B, Vonsattel JP: P301L tauopathy: confocal immunofluorescence study of perinuclear aggregation of the mutated protein. J Neurol Sci 2002, 1-2:85-93
49. Adamec E, Mohan P, Vonsattel JP, Nixon RA: Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2. Acta Neuropathol (Berl) 2002, 104:92-104
50. Glading A, Lauffenburger DA, Wells A: Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 2002, 12:46-54
51. Nixon R: The calpains in aging and aging-related diseases. Aging Res Rev 2003, 2:407-418
52. Schoenwaelder SM, Yuan Y, Jackson SP: Calpain regulation of integrin a lib αllb β 3 signaling in human platelets. Platelets 2000, 11:189-198
53. Moldoveanu T, Hosfield CM, Lim D, Elce JS, Jia Z, Davies PL: A Ca(2+) switch aligns the active site of calpain. Cell 2002, 108:649-660
54. Kesavapany S, Li BS, Pant HC: Cyclin-dependent kinase 5 in neurofilament function and regulation. Neurosignals 2003, 12:252-264
55. Lau LF, Ahlijanian MK: Role of cdk5 in the pathogenesis of Alzheimer's disease. Neurosignals 2003, 12:209-214
56. Lankiewicz S, Marc Luetjens C, True Bui N, Krohn A, Poppe M, Cole G, Saido T, Prehn J: Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death. J Biol Chem 2000, 275:17064-17071
57. Gil-Parrado S, Fernandez-Montalvan A, Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch T, Auerswald EA, Welsh K, Reed J, Fritz H, Fuentes-Prior P, Spiess E, Salvesen G, Machleidt W: Ionomycin-activated calpain triggers apoptosis: a probable role for Bcl-2 family members. J Biol Chem 2002, 277:27217-27226
58. Park J, Koh J: Induction of an immediate early gene egr-1 by zinc through extracellular signal-regulated kinase activation in cortical culture: its role in zinc-induced neuronal death. J Neurochem 1999, 73:450-456
59. Jiang Q, Gu Z, Zhang G, Jing G: Diphosphorylation and involvement of extracellular signal-regulated kinases (ERK1/2) in glutamate-induced apoptotic-like death in cultured rat cortical neurons. Brain Res 2000, 857:71-77
60. Guise S, Braguer D, Carles G, Delacourte A, Briand C: Hyperphosphorolation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J Neurosci Res 2001, 63:257-267
61. Murray B, Alessandrini A, Cole A, Yee A, Furshpan E: Inhibition of the P44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc Natl Acad Sci USA 1998, 95:11975-11980
62. Runden E, Seglen P, Haug F, Ottersen O, Wieloch T, Shamloo M, Laake J: Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci 1998, 18:7296-7305
63. Noshita N, Sugawara T, Hayashi T, Lewen A, Omar G, Chan P: Copper/zinc Superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J Neurosci 2002, 22:7923-7930
64. Man B, Holtzman D: BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000, 20:5775-5781
65. Wang X, Zhu C, Qiu L, Hagberg H, Sandberg M, Blomgren K: Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischaemia. J Neurochem 2003, 86:351-362
66. Abe K, Saito H: Amyloid beta neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons. Neurosci Lett 2000, 292:1-4
67. Pant HC: Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem J 1988, 256:665-658
68. Zentrich E, Han S, Pessoa-Brandao L, Butterfield L, Heasley L: Collaboration of JNKs and ERKs in nerve growth factor regulation of the neurofilament light chain promoter in PC12 cells. J Biol Chem 2002, 277:4110-4118
69. Mocchetti I, Wrathall JR: Neurotrophic factors in central nervous system trauma. J Neurotrauma 1995, 12:853-870
70. Black M, Aletta J, Greene L: Regulation of microtubule composition and stability during nerve growth factor-promoted neurite outgrowth. J Cell Biol 1986, 103:545-557
71. Morfini G, DiTella M, Feiguin F, Carrri N, Caceres A: Neurotrophin-3 enhances neurite outgrowth in cultured hippocampal pyramidal neurons. J Neurosci Res 1994, 39:219-232
72. Xia Z, Dickens M, Raingeaud J, Davis R, Greenberg M: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331
73. Vickers J, Riederer B, Marugg R, Buee-Scherrer V, Buee L, Delacourte A, Morrison J: Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 1994, 62:1-13
74. Lu Q, Soria J, Wood J: p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. J Neurosci Res 1993, 35:439-444